Evidence map›Paper›PMID 42490431›Full record

ArticleScience advances2026

MoCl

Youliang Wang, Lingfeng Zhu, Hai Zhang, Fan Wang, Zhenfang Zhang, Xiaoning Li, Hui Li, Wubin Du, Zhijun Wu, Hongge Pan and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Youliang WangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China.ORCID 0009-0006-1089-0053
Lingfeng ZhuCentre for Atomaterials and Nanomanufacturing (CAN), School of Science, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0009-0009-9093-1119
Hai ZhangSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Fan WangSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.ORCID 0000-0002-8718-0758
Zhenfang ZhangCentre for Atomaterials and Nanomanufacturing (CAN), School of Science, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0003-0307-3697
Xiaoning LiCentre for Atomaterials and Nanomanufacturing (CAN), School of Science, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0001-5991-0955
Hui LiCentre for Atomaterials and Nanomanufacturing (CAN), School of Science, RMIT University, Melbourne, VIC 3000, Australia.
Wubin DuInstitute of Science and Technology for New Energy, Xi'an Technological University, Xi'an 710021, China.ORCID 0000-0002-9396-0275
Zhijun WuInstitute of Science and Technology for New Energy, Xi'an Technological University, Xi'an 710021, China.
Hongge PanInstitute of Science and Technology for New Energy, Xi'an Technological University, Xi'an 710021, China.
Ze ZhangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China.ORCID 0000-0002-6199-8156
Zhenyu YangSchool of Chemistry and Chemical Engineering, Nanchang University, Nanchang 330031, China.ORCID 0000-0003-1857-1779
Tianyi MaCentre for Atomaterials and Nanomanufacturing (CAN), School of Science, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0002-1042-8700

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In situ-polymerized 1,3-dioxolane (DOL) electrolytes offer a promising route to quasi-solid-state lithium metal batteries (QSSLMBs), yet their limited oxidative tolerance and unstable electrode interfaces restrict high-voltage operation. Here, a simulation-guided dual-track regulation strategy uses MoCl

Identifiers

PMID42490431
PMCPMC13394469

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.